Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation

被引:0
|
作者
Lothar C. Dieterich
Luca Ducoli
Jay W. Shin
Michael Detmar
机构
[1] Institute of Pharmaceutical Sciences,Division of Genomic Technologies
[2] Swiss Federal Institute of Technology (ETH) Zurich,undefined
[3] RIKEN Center for Life Science Technologies,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Vascular endothelial growth factors (VEGFs) and their receptors play crucial roles in the formation of blood and lymphatic vessels during embryogenesis, and also under pathologic conditions in the adult. Despite intensive efforts over the last decades to elucidate the precise functions of VEGFs, transcriptional responses to VEGF receptor stimulation are still not fully characterized. To investigate the specific transcriptional effects of VEGFR-2 and VEGFR-3 activation, we performed a correlation analysis of previously published CAGE sequencing and microarray data of human lymphatic endothelial cells (LECs) stimulated with distinct VEGFs acting through either VEGFR-2 or VEGFR-3. We identified that specific activation of VEGFR-3 by VEGF-C156S results in the downregulation of many genes involved in immune regulation and inflammation, suggesting that VEGFR-3 stimulation has direct anti-inflammatory effects. Comparing CAGE and microarray data sets, we furthermore identified a small number of genes that showed a receptor-dependent response in LECs, demonstrating that these receptors, despite activating very similar signaling pathways, fulfill overlapping but not identical functions within the same cell type (LECs).
引用
收藏
相关论文
共 50 条
  • [1] Analysis: Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
    Dieterich, Lothar C.
    Ducoli, Luca
    Shin, Jay W.
    Detmar, Michael
    [J]. SCIENTIFIC DATA, 2017, 4
  • [2] Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas
    Susanne Norgall
    Maria Papoutsi
    Jochen Rössler
    Lothar Schweigerer
    Jörg Wilting
    Herbert A Weich
    [J]. BMC Cancer, 7
  • [3] Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas
    Norgall, Susanne
    Papoutsi, Maria
    Roesler, Jochen
    Schweigerer, Lothar
    Wilting, Joerg
    Weich, Herbert A.
    [J]. BMC CANCER, 2007, 7 (1)
  • [4] Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites
    Dixelius, J
    Mäkinen, T
    Wirzenius, M
    Karkkainen, MJ
    Wernstedt, C
    Alitalo, K
    Claesson-Welsh, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) : 40973 - 40979
  • [5] Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
    Favier, Benoit
    Alam, Antoine
    Barron, Pauline
    Bonnin, Jacques
    Laboudie, Patricia
    Fons, Pierre
    Mandron, Marie
    Herault, Jean-Pascal
    Neufeld, Gera
    Savi, Pierre
    Herbert, Jean-Marc
    Bono, Francoise
    [J]. BLOOD, 2006, 108 (04) : 1243 - 1250
  • [6] Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity
    Alam, A
    Herault, JP
    Barron, P
    Favier, B
    Fons, P
    Delesque-Touchard, N
    Senegas, I
    Laboudie, P
    Bonnin, J
    Cassan, C
    Savi, P
    Ruggeri, B
    Carmeliet, P
    Bono, FO
    Herbert, JM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) : 909 - 915
  • [7] Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development
    Saharinen, Pipsa
    Helotera, Hanna
    Miettinen, Juho
    Norrmen, Camilla
    D'Amico, Gabriela
    Jeltsch, Michael
    Langenberg, Tobias
    Vandevelde, Wouter
    Ny, Annelii
    Dewerchin, Mieke
    Carmeliet, Peter
    Alitalo, Kari
    [J]. GENES & DEVELOPMENT, 2010, 24 (09) : 875 - 880
  • [8] Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis
    Goldman, Jeremy
    Rutkowski, Joseph M.
    Shields, Jacqueline D.
    Pasquier, Miriella C.
    Cui, Yingjie
    Schmoekel, Hugo G.
    Willey, Stephen
    Hicklin, Daniel J.
    Pytowski, Bronislaw
    Swartz, Melody A.
    [J]. FASEB JOURNAL, 2007, 21 (04): : 1003 - 1012
  • [9] Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
    Padera, Timothy P.
    Kuo, Angera H.
    Hoshida, Tohru
    Liao, Shan
    Lobo, Jennifer
    Kozak, Kevin R.
    Fukumura, Dai
    Jain, Rakesh K.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (08) : 2272 - 2279
  • [10] CLINICAL SIGNIFICANCE OF VEGFR-2 AND VEGFR-3 EXPRESSION IN OVARIAN CANCER PATIENTS
    Klasa-Mazurkiewicz, Dagmara
    Jarzab, Miroslaw
    Milczek, Tomasz
    Lipinska, Barbara
    Emerich, Janusz
    [J]. POLISH JOURNAL OF PATHOLOGY, 2011, 62 (01) : 31 - 40